Preliminary data from experiments in which we transferred in vitro activated PerC- and splenic B cells to mice before the induction of proteoglycan-induced arthritis, did not demonstrate an apparent disease-dampening effect for PerC B cells whereas activated splenic B cells seemed to worsen disease (unpublished observations). The gene discussed is PPARGC1B; the disease is arthritic joint disease.